Search Results - "Mehlis, Katja"

Physicians' attitudes towards secondary use of clinical data for biomedical research purposes in Germany. Results of a quantitative survey by Köngeter, Anja, Schickhardt, Christoph, Jungkunz, Martin, Mehlis, Katja, Winkler, Eva C

“…For biomedical data-driven research purposes, secondary use of clinical data carries great but largely untapped potential. Physicians' attitudes and their…”
Get full text

Patients’ Willingness to Provide Their Clinical Data for Research Purposes and Acceptance of Different Consent Models: Findings From a Representative Survey of Patients With Cancer by Köngeter, Anja, Schickhardt, Christoph, Jungkunz, Martin, Bergbold, Susanne, Mehlis, Katja, Winkler, Eva C

“…Background Secondary use of clinical data for biomedical research purposes holds great potential for various types of noninterventional, data-driven studies…”
Get full text

The patient-level effect of the cost of Cancer care - financial burden in German Cancer patients by Mehlis, Katja, Witte, Julian, Surmann, Bastian, Kudlich, Matthias, Apostolidis, Leonidas, Walther, Jürgen, Jäger, Dirk, Greiner, Wolfgang, Winkler, Eva C

“…Financial toxicity of cancer has so far been discussed primarily in the US health care system and is associated with higher morbidity and mortality. In…”
Get full text

Commentary 1: (Self-)reflexivity and External Monitoring by Mehlis, Katja, Schildmann, Jan

Get full text

The COVID-19 Pandemic and Cancer Patients in Germany: Impact on Treatment, Follow-Up Care and Psychological Burden by Eckford, Rachel D, Gaisser, Andrea, Arndt, Volker, Baumann, Michael, Kludt, Evelyn, Mehlis, Katja, Ubels, Jasper, Winkler, Eva C, Weg-Remers, Susanne, Schlander, Michael

“…In response to the ongoing coronavirus disease 2019 (COVID-19) pandemic, governments imposed various measures to decrease the rate of disease spread, and…”
Get full text

Late decisions about treatment limitation in patients with cancer: empirical analysis of end-of-life practices in a haematology and oncology unit at a German university hospital by Mehlis, Katja, Bierwirth, Elena, Laryionava, Katsiaryna, Mumm, Friederike, Heussner, Pia, Winkler, Eva C

“…BackgroundDecisions to limit treatment (DLTs) are important to protect patients from overtreatment but constitute one of the most ethically challenging…”
Get full text

Secondary Use of Clinical Data in Data-Gathering, Non-Interventional Research or Learning Activities: Definition, Types, and a Framework for Risk Assessment by Jungkunz, Martin, Köngeter, Anja, Mehlis, Katja, Winkler, Eva C, Schickhardt, Christoph

“…Background The secondary use of clinical data in data-gathering, non-interventional research or learning activities (SeConts) has great potential for…”
Get full text

High prevalence of moral distress reported by oncologists and oncology nurses in end‐of‐life decision making by Mehlis, Katja, Bierwirth, Elena, Laryionava, Katsiaryna, Mumm, Friederike H.A., Hiddemann, Wolfgang, Heußner, Pia, Winkler, Eva C.

“…Objective Decisions to limit life‐prolonging treatment (DLT) are often accompanied by psychological and ethical difficulties. The aim of the study is to…”
Get full text

Patient-Reported Financial Distress in Cancer: A Systematic Review of Risk Factors in Universal Healthcare Systems by Pauge, Sophie, Surmann, Bastian, Mehlis, Katja, Zueger, Andrea, Richter, Luise, Menold, Natalja, Greiner, Wolfgang, Winkler, Eva C.

“…Financial toxicity is a side effect of cancer that results from the perceived financial distress an individual may experience in the course of the disease. The…”
Get full text

Financial toxicity in patients with colorectal cancer and neuroendocrine tumors by Apostolidis, Leonidas, Mehlis, Katja, Witte, Julian, Surmann, Bastian, Kudlich, Matthias, Walther, Juergen, Greiner, Wolfgang, Winkler, Eva Caroline

“…Abstract only…”
Get full text

Room for improvement regarding patient involvement in decisions to limit treatment: Results from the EPAL-study (Ethics Policy for Advanced Care Planning and Limiting Treatment) by Winkler, Eva Caroline, Mehlis, Katja, Jaeger, Elena, Laryionava, Katsiaryna, Mumm, Friederike, Hiddemann, Wolfgang, Heussner, Pia

“…Abstract only…”
Get full text

Development and Evaluation of an Ethical Guideline for Decisions to Limit Life-Prolonging Treatment in Advanced Cancer: Protocol for a Monocentric Mixed-Method Interventional Study by Laryionava, Katsiaryna, Mehlis, Katja, Bierwirth, Elena, Mumm, Friederike, Hiddemann, Wolfgang, Heußner, Pia, Winkler, Eva C

“…Many patients with advanced cancer receive chemotherapy close to death and are referred too late to palliative or hospice care, and therefore die under therapy…”
Get full text

Individual financial burden following a cancer diagnosis from the perspective of social services in Germany by Surmann, Bastian, Lingnau, Ruth, Witte, Julian, Walther, Jürgen, Mehlis, Katja, Winkler, Eva C, Greiner, Wolfgang

“…In addition to physical, psychological and social effects, economic effects and the associated financial burden of a cancer diagnosis may also gain in…”
Get full text

Trust and responsibility in molecular tumour boards by Merry, David, Schickhardt, Christoph, Mehlis, Katja, Winkler, Eva C.

“…Molecular tumour boards (MTBs) offer recommendations for potentially effective, but potentially burdensome, molecularly targeted treatments to a patient's…”
Get full text

Krebs und die finanziellen Auswirkungen für Betroffene: Konzeptualisierung und erste Ergebnisse einer Validierungsstudie by Züger, Andrea, Richter, Luise, Pauge, Sophie, Mehlis, Katja, Winkler, Eva

“…Zusammenfassung Eine Krebserkrankung kann vielschichtige finanzielle Folgen für Betroffene haben. In einer Validierungsstudie zur Erfassung von finanziellen…”
Get full text

The Role of Physicians in Rationing Cancer Care. Attitudes of German Oncologists by Fernau, Sandra, Mehlis, Katja, Schildmann, Jan, Krause, Stefan, Winkler, Eva C

“…Against the background of limited resources, the rise in the cost of therapy as well as in the number of cancer patients fuels the discussion about the…”
Get more information

Frequency and Timing of Decisions to Limit Intensive Medical Care and Tumor-Specific Therapy in University Hematology and Oncology by Mehlis, Katja, Becker, Christina, Christ, Carola, Laryionava, Katsiaryna, Hiddemann, Wolfgang, Heußner, Pia, Winkler, Eva Caroline

“…Decisions to limit treatment (DLT) are important in order to prevent overtreatment at the end of life. However, they are not always discussed with the patient…”
Get more information

Finanzielle Auswirkung von Krebserkrankungen und sozialethische Implikationen by Mehlis, Katja, Surmann, Bastian, Winkler, Eva C.

“…Zusammenfassung Hintergrund Während über patientenseitige finanzielle Auswirkungen einer Krebserkrankung bislang v. a. für das US-amerikanische…”
Get full text

Individuelle finanzielle Belastungen infolge einer Krebserkrankung aus der Perspektive von Sozialdiensten in Deutschland by Surmann, Bastian, Lingnau, Ruth, Witte, Julian, Walther, Jürgen, Mehlis, Katja, Winkler, Eva C., Greiner, Wolfgang

“…Neben physischen, psychischen und sozialen Auswirkungen können bei längeren Krankheitsverläufen auch finanzielle Auswirkungen und damit einhergehende…”
Get full text

Haben Patientinnen die moralische Pflicht, ihre klinischen Daten für Forschung bereitzustellen? Eine kritische Prüfung möglicher Gründe by Jungkunz, Martin, Köngeter, Anja, Mehlis, Katja, Spitz, Markus, Winkler, Eva C., Schickhardt, Christoph

“…Zusammenfassung Die Sekundärnutzung klinischer Daten für Forschungs- und Lernaktivitäten hat das Potenzial, medizinisches Wissen und klinische Versorgung…”
Get full text